Diebold Nixdorf (DBD) Fundamental Analysis: Revenue, Earnings & Valuation

5.69 / 10

Netural

Fundamental assessment rates the stock neutral at 5.7/10. Positive drivers include strong Net‑income‑Revenue and efficient Operating Cycle, while Revenue‑to‑Market‑Value and cash‑related ratios lag. Long‑term debt to working capital is modest. Overall fundamentals suggest caution.

Analysis Checks(6/10)

Revenue-MV

Value1.25

Score1/3

Weight-5.04%

1M Return-3.44%

Operating cycle

Value123.04

Score3/3

Weight10.15%

1M Return5.17%

Profit-MV

Value0.52

Score2/3

Weight4.16%

1M Return2.61%

Net income-Revenue

Value-0.93

Score3/3

Weight10.59%

1M Return5.71%

PB-ROE

Value-0.40

Score2/3

Weight6.71%

1M Return3.71%

Cash-UP

Value1.48

Score0/3

Weight-11.82%

1M Return-10.64%

Long-term debt to working capital ratio (%)

Value3.32

Score1/3

Weight0.24%

1M Return0.12%

Asset-MV

Value-0.55

Score2/3

Weight92.33%

1M Return34.00%

Inventory turnover days

Value66.39

Score2/3

Weight0.20%

1M Return0.11%

Cash-MV

Value1.08

Score1/3

Weight-7.52%

1M Return-4.14%

Is DBD undervalued or overvalued?

DBD scores 5.69/10 on fundamentals and holds a Fair valuation at present. Backed by its 9.26% ROE, 2.56% net margin, 29.50 P/E ratio, 2.53 P/B ratio, and 684.09% earnings growth, these metrics solidify its Netural investment rating.